About DAP+

The Diabetes Alliance Program (DAP) began in 2015 as a partnership between Hunter New England Local Health District and the Hunter New England and Central Coast Primary Health Network and transitioned from a pilot program in 2015 to business as usual in 2017.

This collaboration allowed the cross-organisational sharing of skills, knowledge, and resources to develop a person-centred model of care that is efficient, cost-effective, and sustainable. 

Prior to the introduction of DAP, people living with diabetes in regional and remote areas relied either solely on their local GP and community health services for care provision or were required to travel to metropolitan centres to access care.

The introduction of DAP has allowed primary care and specialist teams to work seamlessly to provide the best care in a team approach as close to home as possible for patients.

Program expansion

In 2023 the Diabetes Alliance Program Initiative expanded to become the Diabetes Alliance Program Plus (DAP+) thanks to a generous philanthropic gift from the Colonial Foundation awarded in 2022.

Two new partners officially joined the collaboration and expanded the partnership to include Hunter Medical Research Institute and The University of Newcastle

The expansion will allow the program to:

  • Have an increased focus on regional and rural communities;

  • Continue the existing DAP model but extend it to provide additional support for clinicians caring for people with diabetes across the Hunter New England Region, including smartphone apps, advice lines, and telehealth;

  • Incorporate robust research into DAP+, including health economics and how the program is benefiting the health system;

  • Look to offer the program beyond the Hunter New England region, to other areas of NSW from 2025.

The end goal of the Alliance is for all people with diabetes in our region to have access to gold-standard care that leads to improved clinical outcomes. 

Learn more here

Read DAP+ Impact Report (2024) here

Read DAP+ Impact Report (2023) here